Krishna Institute of Medical Sciences Limited (KIMS.BO)
INR 654.95
(1.57%)
INR 654.95
(1.57%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 15.45 Billion INR | 2.07% |
| 2022 | 13.7 Billion INR | 32.58% |
| 2021 | 10.33 Billion INR | 26.21% |
| 2020 | 8.19 Billion INR | 22.17% |
| 2019 | 6.7 Billion INR | 23.07% |
| 2018 | 5.44 Billion INR | 229.42% |
| 2017 | 1.65 Billion INR | 52.6% |
| 2016 | 1.08 Billion INR | 6.63% |
| 2015 | 1.01 Billion INR | -54.96% |
| 2014 | 2.25 Billion INR | 1065.28% |
| 2013 | 193.65 Million INR | -37.43% |
| 2012 | 309.5 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.88 Billion INR | 12.64% |
| 2023 Q4 | 3.44 Billion INR | -8.34% |
| 2023 FY | 13.98 Billion INR | 2.07% |
| 2023 Q1 | 3.72 Billion INR | 2.77% |
| 2023 Q2 | 4.06 Billion INR | 9.21% |
| 2023 Q3 | 3.76 Billion INR | -7.48% |
| 2022 Q1 | 3.02 Billion INR | 30.5% |
| 2022 FY | 13.7 Billion INR | 32.58% |
| 2022 Q4 | 3.62 Billion INR | 3.02% |
| 2022 Q3 | 3.51 Billion INR | -0.89% |
| 2022 Q2 | 3.54 Billion INR | 17.25% |
| 2021 Q2 | 2.62 Billion INR | -8.88% |
| 2021 Q3 | 2.5 Billion INR | -4.71% |
| 2021 Q4 | 2.31 Billion INR | -7.43% |
| 2021 Q1 | 2.88 Billion INR | 28.23% |
| 2021 FY | 10.33 Billion INR | 26.21% |
| 2020 Q3 | 2.26 Billion INR | -12.23% |
| 2020 Q1 | 1.11 Billion INR | -25.8% |
| 2020 FY | 8.19 Billion INR | 22.17% |
| 2020 Q4 | 2.24 Billion INR | -0.72% |
| 2020 Q2 | 2.58 Billion INR | 131.59% |
| 2019 FY | 6.7 Billion INR | 23.07% |
| 2019 Q4 | 1.5 Billion INR | 0.0% |
| 2018 FY | 5.44 Billion INR | 229.42% |
| 2017 FY | 1.65 Billion INR | 52.6% |
| 2017 Q2 | 886.73 Million INR | 0.0% |
| 2017 Q1 | 886.73 Million INR | 0.0% |
| 2016 FY | 1.08 Billion INR | 6.63% |
| 2015 FY | 1.01 Billion INR | -54.96% |
| 2014 FY | 2.25 Billion INR | 1065.28% |
| 2013 FY | 193.65 Million INR | -37.43% |
| 2012 FY | 309.5 Million INR | 0.0% |